GLOBAL HOME

 
Oculus Innovative Sciences is a biopharmaceutical company with a proprietary Microcyn® Technology platform intended to help prevent and treat infections in wounds and infectious diseases. We are focused on the development, manufacturing and marketing of various technology applications formulated with Microcyn®.
A New Era In Anti-Infectives  
 

Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a wide spectrum of products based upon the shelf-stable Microcyn® Technology platform, which is intended to help prevent and treat infections in wounds, burns and diseases. Microcyn has demonstrated the ability to safety treat a wide range of pathogens, including antibiotic-resistant strains of bacteria such as MRSA, viruses, fungi and spores.


Latest News
.Oculus Innovative Sciences to Present at Canaccord Adams 28th Annual....Oculus Innovative Sciences Reports 59% Increase in First Quarter Product....Oculus Innovative Sciences Announces Fiscal First Quarter Financial Results....Oculus Innovative Sciences' CEO and Founder Named One of Pharmaceutical....Oculus Innovative Sciences Announces Positive Results from Abstract....
more >
Upcoming Events
.September 9, 2008
Next Generation Small and MidCap Investor Conference
Westin Hotel Times Square
New York.September 18-20, 2008
DLS (Diabetic Limb Salvage Conference)
JW Marriott (Pennsylvania Ave)
Washington D.C
www.dlsconference.com.October 13-14, 2008
Jesup & Lamont Fall Life Sciences Conference
Le Parker Meridien
New York, NY
.October 25-28, 2008
ICAAC/IDSA (Interscience conference on Antimicrobial Agents & Chemotherapy/Infectious Disease Society)
Washington D.C
www.icaac.org.October 27-30, 2008
CSASWC (Clinical Symposium on Advances in Skin and Wound Care)
Rio Hotel & Casino
Las Vegas, NV
www.symposiumonwoundcare.com.
more >